Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: A feasibility study

Clinical Chemistry

Volumn 48, Issue 5, 2002, Pages 778-780

  Chiu, Rossa W K ^a   Lau, Tze K ^a   Cheung, Pik T ^a   Gong, Zhi Q ^a   Leung, Tse N ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA; STEROID 21 MONOOXYGENASE;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA POLYMORPHISM; FEMALE; GENE LOCUS; HUMAN; MALE; MATERNAL PLASMA; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS;

EID: 0036231537     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.5.778     Document Type: Article

References (20)

1. Presence of fetal DNA in maternal plasma and serum
2. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma
3. Detection of fetal RHD-specific sequences in maternal plasma
4. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma
5. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma
6. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
7. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
8. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia
9. Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese
10. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism
11. Novel mutations in the human CYP21 gene
12. Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency
13. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma
14. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
15. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees
16. Characterization of frequent polymorphisms in intron 2 of CYP21: Application to analysis of segregation of CYP21 alleles
17. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
18. Rapid clearance of fetal DNA from maternal plasma
19. Nomenclature for factors of the HLA system, 2000